Skip to main content
. 2021 Mar 18;15:569424. doi: 10.3389/fncel.2021.569424

Figure 5.

Figure 5

Silencing of ALK5 attenuates the promoting effect of TMAO on astrocyte proliferation, migration and viability. (A) Transfection efficiency of ALK5 in cells examined using RT-qPCR. (B) Protein expression of ALK5 in cells analyzed using Western blotting. (C) Expression of ALK5 and Smurf2 in cells determined by Western blotting. (D) Cell viability evaluated using CCK-8 assay. (E) Cell proliferation evaluated using EdU assay. (F), Cell migration evaluated using Transwell assay. (G), The expression of GFAP, Neurocan and Phosphacan in each group of cells detected by Western blotting. *p < 0.05 compared with the sh-NC group or the TMAO + oe-NC group. NS, p > 0.05 compared with the TMAO group. Unpaired t-test is adopted for data comparison between two groups. One-way ANOVA is employed for data comparison among multiple groups followed by Tukey's post hoc test.